HeartSciences receives Nasdaq delisting notice for equity shortfall; plans merger to regain compliance

HeartSciences Inc.

• Nasdaq notified HeartSciences on Aug 4, 2026 of non-compliance with Rule 5550(b)(1) requiring $2.5M stockholders' equity.
• Company reported stockholders' equity of $226,060 as of April 30, 2026; must submit compliance plan by Sept 18, 2026.
• If plan accepted, extension until Jan 31, 2027 to regain compliance; otherwise risk of suspension/delisting.
• Company intends to use all-stock merger with Fortitude Mining Holdings (agreed June 23, 2026) to regain compliance.
• No immediate impact on listing; shares and warrants continue trading on Nasdaq.